Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy

Annals of Neurology

Volumn 69, Issue 1, 2011, Pages 100-110

  Lehmann, Helmar C ^a,b   Chen, Weiran ^a   Borzan, Jasenka ^a   Mankowski, Joseph L ^a,c   Höke, Ahmet ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; AXOPLASM; BRAIN MITOCHONDRION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACACA; MALE; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL GENETICS; MITOCHONDRIAL RESPIRATION; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; SENSORY NERVE; SENSORY NEUROPATHY; SIMIAN IMMUNODEFICIENCY VIRUS; SPINAL GANGLION; SURAL NERVE; VIRUS STRAIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANIMALS; AXONS; DISEASE MODELS, ANIMAL; DNA DAMAGE; DNA, MITOCHONDRIAL; FEMALE; HIV INFECTIONS; HUMANS; MACACA FASCICULARIS; MACACA NEMESTRINA; MALE; MIDDLE AGED; MITOCHONDRIA; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYNEUROPATHIES; SENSATION DISORDERS; SEQUENCE DELETION;

EID: 79551502732     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22150     Document Type: Article

References (50)

1. Keswani SC, Pardo CA, Cherry CL, et al. HIV-associated sensory neuropathies. AIDS 2002; 16: 2105-2117.
2. McArthur JC, Brew BJ, Nath A., Neurological complications of HIV infection. Lancet Neurol 2005; 4: 543-555.
3. Cornblath DR, Hoke A., Recent advances in HIV neuropathy. Curr Opin Neurol 2006; 19: 446-450.
4. Childs EA, Lyles RH, Selnes OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999; 52: 607-613.
5. Simpson DM, Haidich AB, Schifitto G, et al. Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS 2002; 16: 407-412.
6. Evans S, Clifford D, Chen H, et al. HIV-associated peripheral neuropathy in the HAART era: results from AIDS Clinical Trials Group Longitudinal Linked Randomized Trials Protocol A5001. Presented at: Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada.
7. Cornblath DR, McArthur JC., Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988; 38: 794-796.
8. Zhou L, Kitch DW, Evans SR, et al. Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy. Neurology 2007; 68: 2113-2119.
9. Canter JA, Haas DW, Kallianpur AR, et al. The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy. Pharmacogenomics J 2008; 8: 71-77.
10. Kwong JQ, Beal MF, Manfredi G., The role of mitochondria in inherited neurodegenerative diseases. J Neurochem 2006; 97: 1659-1675.
11. Corral-Debrinski M, Horton T, Lott MT, et al. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 1992; 2: 324-329.
12. Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC., Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res 1992; 275: 169-180.
13. Corral-Debrinski M, Horton T, Lott MT, et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 1994; 23: 471-476.
14. Mawrin C, Kirches E, Krause G, et al. Region-specific analysis of mitochondrial DNA deletions in neurodegenerative disorders in humans. Neurosci Lett 2004; 357: 111-114.
15. Navarro A, Boveris A., The mitochondrial energy transduction system and the aging process. Am J Physiol 2007; 292: C670-C686.
16. Dinoso JB, Rabi SA, Blankson JN, et al. A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J Virol 2009; 83: 9247-9257.
17. Clements JE, Mankowski JL, Gama L, Zink MC., The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: from mechanism to treatment. J Neurovirol 2008; 14: 309-317.
18. Ebenezer GJ, Laast VA, Dearman B, et al. Altered cutaneous nerve regeneration in a simian immunodeficiency virus / macaque intracutaneous axotomy model. J Comp Neurol 2009; 514: 272-283.
19. Laast VA, Pardo CA, Tarwater PM, et al. Pathogenesis of simian immunodeficiency virus-induced alterations in macaque trigeminal ganglia. J Neuropathol Exp Neurol 2007; 66: 26-34.
20. Mankowski JL, Queen SE, Fernandez CS, et al. Natural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaques. PLoS One 2008; 3: e3603.
21. van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE., Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med 1999; 160: 1-9.
22. Hattori K, Tanaka M, Sugiyama S, et al. Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am Heart J 1991; 121: 1735-1742.
23. Yen TC, Su JH, King KL, Wei YH., Ageing-associated 5 kb deletion in human liver mitochondrial DNA. Biochem Biophys Res Commun 1991; 178: 124-131.
24. Wei YH., Mitochondrial DNA alterations as ageing-associated molecular events. Mutat Res 1992; 275: 145-155.
25. Zink MC, Laast VA, Helke KL, et al. From mice to macaques-animal models of HIV nervous system disease. Curr HIV Res 2006; 4: 293-305.
26. Hunter DR, Haworth RA, Southard JH., Relationship between configuration, function, and permeability in calcium-treated mitochondria. J Biol Chem 1976; 251: 5069-5077.
27. Bender A, Krishnan KJ, Morris CM, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006; 38: 515-517.
28. Horton TM, Graham BH, Corral-Debrinski M, et al. Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington's disease patients. Neurology 1995; 45: 1879-1883.
29. Dalakas MC., Peripheral neuropathy and antiretroviral drugs. J Peripher Nerv Syst 2001; 6: 14-20.
30. Dalakas MC, Semino-Mora C, Leon-Monzon M., Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC). Lab Invest 2001; 81: 1537-1544.
31. Johnson AA, Ray AS, Hanes J, et al. Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J Biol Chem 2001; 276: 40847-40857. (Pubitemid 37373231)
32. Keswani SC, Chander B, Hasan C, et al. FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann Neurol 2003; 53: 57-64.
33. Keswani SC, Buldanlioglu U, Fischer A, et al. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann Neurol 2004; 56: 815-826.
34. Zhu Y, Antony JM, Martinez JA, et al. Didanosine causes sensory neuropathy in an HIV/AIDS animal model: impaired mitochondrial and neurotrophic factor gene expression. Brain 2007; 130: 2011-2023.
35. Griffin JW, Hoke A, Nguyen T., Axon degeneration and rescue. In:, Selzer ME, Cohen LG, Clarke S, et al, eds. Textbook of neural repair and rehabilitation. Vol 1. Cambridge, UK: Cambridge Press, 2006: 293-302.
36. Bristow EA, Griffiths PG, Andrews RM, et al. The distribution of mitochondrial activity in relation to optic nerve structure. Arch Ophthalmol 2002; 120: 791-796.
37. Wang SS, Shultz JR, Burish MJ, et al. Functional trade-offs in white matter axonal scaling. J Neurosci 2008; 28: 4047-4056.
38. Ritchie JM., The oxygen consumption of mammalian non-myelinated nerve fibres at rest and during activity. J Physiol 1967; 188: 309-329.
39. Ritchie JM., Energetic aspects of nerve conduction: the relationships between heat production, electrical activity and metabolism. Prog Biophys Mol Biol 1973; 26: 147-187.
40. Stys PK, Waxman SG, Ransom BR., Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J Neurosci 1992; 12: 430-439.
41. Waxman SG., Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosis. Trends Mol Med 2006; 12: 192-195.
42. Blaker WD, Goodrum JF, Morell P., Axonal transport of the mitochondria-specific lipid, diphosphatidylglycerol, in the rat visual system. J Cell Biol 1981; 89: 579-584.
43. Friede RL, Ho KC., The relation of axonal transport of mitochondria with microtubules and other axoplasmic organelles. J Physiol 1977; 265: 507-519.
44. Ochs S, Worth RM, Chan SY., Calcium requirement for axoplasmic transport in mammalian nerve. Nature 1977; 270: 748-750.
45. Misgeld T, Kerschensteiner M, Bareyre FM, et al. Imaging axonal transport of mitochondria in vivo. Nat Methods 2007; 4: 559-561.
46. Polydefkis M, Hauer P, Sheth S, et al. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 2004; 127: 1606-1615.
47. Cherry CL, Affandi JS, Imran D, et al. Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology 2009; 73: 315-320.
48. Cheng YJ, Gregg EW, Kahn HS, et al. Peripheral insensate neuropathy-a tall problem for US adults? Am J Epidemiol 2006; 164: 873-880.
49. Robinson LR, Stolov WC, Rubner DE, et al. Height is an independent risk factor for neuropathy in diabetic men. Diabetes Res Clin Pract 1992; 16: 97-102.
50. Sosenko JM, Boulton AJ, Gadia MT, et al. The association between symptomatic sensory neuropathy and body stature in diabetic patients. Diabetes Res Clin Pract 1988; 4: 95-98.